Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of fluorinated drug candidates where the bromomethyl group enables further functionalization through cross-coupling reactions. Its structure supports the introduction of fluorine, which can enhance metabolic stability and bioavailability in active pharmaceutical ingredients. Also employed in the preparation of agrochemicals and specialty organic compounds requiring selective substitution patterns on aromatic rings. The compound’s reactivity makes it valuable in building complex molecules in medicinal chemistry research.